December 11, 2017

Wesco Aircraft Holdings, Inc IPO

Wesco Aircraft Holdings is a supply chain management provider for the aerospace industry based in Valencia, California. Founded in 1953, Westco has more than 1,000 employees and over 7,000 customers.


Wesco provides logistic solutions and comprehensive stocking programs for nearly every original equipment manufacturer in the aerospace industry.

Wesco announced the terms of their IPO on July 15, 2011, with an initial public offering of 21 million shares set to price in the range of $15.50 to $17.50. The lead underwriters are Barclays Capital and Morgan Stanley. Wesco will trade on the NYSE under the stock symbol WAIR.

For the 12 months ending March 31, 2011, Wesco booked $695 million dollars in sales.

Wesco Aircraft Holdings, Inc S-1/A Form

Wesco Aircraft Holdings, Inc

Wall Street Journal

Endocyte IPO

Endocyte is a West Lafayette, Indiana, biopharmaceutical company that develops Small Molecule Drug Conjugates (SMDC) to improve the efficiency and targeting of cancer drugs, designed to lead them directly to the diseased cells.


Endocyte currently has six drugs undergoing clinical trials. Its most advanced and promising drug, called EC145, is a chemotherapy agent for the treatment of ovarian and lung tumors. The drug works by attaching itself to the vitamin folate, tricking the cancer cells into absorbing the drug thinking it is the vitamin alone, while avoiding healthy cells.

In addition to EC145, Endocyte is working on drugs for prostrate cancer and inflammatory diseases. The company believes that their proprietary technology, called Small Molecule Drug Conjugates (SMDC) will be able to treat diseases like atherosclerosis, rheumatoid arthritis, osteoarthritis as well as advanced kidney cancer.

Endocyte was founded in 1995 by Philip Low, a PhD chemist at Purdue University, and Ron Ellis, now the company’s President and CEO. Dr. Low, with fellow Purdue chemist, Dr. Chris Leamon, worked in the late 1980s on a way to exploit the folate receptors of cells to deliver molecules within the cells. Their results were published in 1991 and began to attract investors interested in the technology. Dr. Low then joined with Ron Ellis to found Endocyte.

EC145 was invented in 2004 and entered clinical trials in 2006. The drug is currently in Phase 3 clinical trials, the only drug to ever reach phase 3 found to be effective against ovarian cancer that is resistant to platinum-based drugs.

Endocyte is also developing a companion diagnostic agent, called EC20, which is designed to predict the patient’s response to EC145. It works by replacing the actual EC145 drug payload with an imaging agent, allowing researchers to identify likely responders to the drug.

Endocyte’s IPO was on Feb. 4, 2011, with 12.5 million shares priced at $6.00. The offering was underwritten by the Royal Bank of Canada and Leerink Swann and Co. On its first day of trading Endocyte rose 29%, closing at $7.73. Initially, Endocyte proposed offering 5.35 million shares in the range of $13 to $15, later cutting the price to $7.00, with 10.7 million shares offered, before settling on the final figures.

As of July 14, Endocyte trades on the NASDAQ at $13.89.

Endocyte S-1 Form

Endocyte Website

Bloomberg

University of Cincinnati Academic Health Center

Chefs’ Warehouse Holdings, LLC IPO

Chefs’ Warehouse Holdings, LLC is a distributor of specialty food products and focuses on filling the need of chefs who own or operate independent restaurants, fine dining establishments, culinary schools and country clubs. The company was founded in 1985 and currently employs about 570 people.


Among Chefs’ Warehouse Holdings gourmet products are truffles, caviar, hormone free meat, and specialty cheeses. Operating out of Ridgefield,

Connecticut, it is a leading high end food distributor in cities such as New York, San Fransisco and Los Angeles.

Chefs’ Warehouse Holdings filed to go public in April of 2011 with an initial expected offering of 8,000,000 shares priced at $14-$16 per share. The lead underwriters are BMO Capital Markets Corp, Jefferies & Company, Inc and

Wells Fargo Securities, LLC. It will be trading on NASDAQ with the ticker symbol CHEF.

Revenues in for Chefs’ Warehouse Holdings in 2010 were $330 million with net income at $15.87 million and a one year sales growth of 21.8%.

Learn more, click here:

Chefs’ Warehouse Holdings, LLC S-1/A Form

Chefs’ Warehouse Holdings, LLC

MSN Money Central

American Midstream Partners, LP IPO

American Midstream Partners L.P is a Limited Partnership based in Denver, Colorado. It was formed in 2009 to purchase, develop and operate natural gas energy assets. It operates approximately 1400 miles of pipeline that gathers and transports over 500 MMcf/d of natural gas. The primary locations are Alabama, Louisiana, Mississippi, Tennessee and Texas.

The Initial Public Offering will be 3.75 million units with an estimated cost of $19-$21 per share. Based on this range, American Midstream Partners expects to raise $75 million. The underwriters have the option to purchase an additional 562,500 units in the event of over-allotments.

The funds raised are for purposes including debt repayment. In the first quarter of 2011, the company’s loss increased to $3.4 million, as opposed to $1.4 million a year previously. This was due to an unrealized loss on derivatives and an increase in operating costs.

The S-1 form was filed on July 15th with the United States Securities and Exchange Commission.The IPO is being underwritten by Citi and BofA Merrill Lynch, and will be listed on the New York Stock Exchange with the symbol AMID.

For more information, click here:

American Midstream Partners, LP S-1/A Form

American Midstream Partners, LP

MarketWatch – The Wall Street Journal Digital Network

Wildcap Energy Inc. IPO

Wildcap Energy Inc. is a development-stage company based in Santa Ana, California. Formerly known as WildCap Energy Storage Devices, Inc., the company’s focus is vertical axis wind turbines.

A license agreement between the University of Arizona and Wildcap grants the company the option to commercialize an innovative technology developed at the university. Wildcap reports that vertical axis turbines are simpler, quieter, less costly and omnidirectional.

While the current market consists of turbine farms distributing energy, Wildcap targets the end users and offers them the cost-saving benefit of generating their own electricity.

Wildcap Energy Inc. filed an initial offering of 680,000 shares at an expected price of $1. The lead underwriter is SUTI Holdings LP. The common stock is being offered by the stockholders; therefore, Wildcap will not receive any proceeds from the sale of the shares.

Wildcap Energy Inc. S-1/A Form

Wildcap Energy Inc.

Bloomberg Businessweek Company Overview

Zillow IPO

Seattle Washington based Zillow Inc is set to join the recent cavalcade of internet companies going public when it debuts next week on the Nasdaq Global Market with an initial product offering of 3,462,000 shares. The IPO is underwritten by CITI and the company hopes to raise about $59 – $71 million dollars with shares in the price range of $16-$18.

UPDATE:  Zillow has set the price for their IPO at $20 per share, which is above their expected range.  This will give them an initial valuation of almost $540 million.  Trading in Zillow shares begin Wednesday July 20, using the ticker symbol Z on the NASDAQ exchange.

Founded in 2005, industry leading Zillow is a vast online real estate resource offering property value estimates, sales histories, and listings of millions of homes available for sale or rental. Among the website’s features are custom loan quotes and a mobile application available for iPhone, iPad, Android and Blackberry that can show nearby homes on an aerial map complete with property histories and estimated values.

Zillow includes data on 100 million homes in the USA, including those for sale and those not on the market. It boasts over 22 million unique monthly users and is one of the top five most visited real estate websites in the USA. Zillow generates revenue from advertising with local real estate professionals and pay per click display ads. The website has not yet made a profit since its launch in 2006 but growth has been strong with revenue growing 74% from 2010 to 2011. Proceeds from the IPO are expected to be used to increase visibility in the marketplace and increase financial flexibility.

Initially Zillow planned to offer shares at a price range between $12 to $14 but in a recently revised filing increased the price to $16-$18. The price increase could give Zillow a valuation near $500 million. A private placement of stock with Technology Crossover Ventures is expected to raise another $5.5 million.

Shares of Zillow are expected to begin trading the week of July 18, 2011 and will trade under ticker symbol “Z”.

Resource links:

Zillow S-1/A Form

Zillow

Techcrunch

Dow Jones Financial Information Services

Thunderclap Entertainment, Inc. IPO

Thunderclap Entertainment, Inc. is a Santa Monica, CA, based company. Currently in the developmental stage, the company is looking to develop and produce high quality films within a budget, maximizing its value by selecting projects according to profitability. It intends to develop and acquire content according to certain demographics and the requirements of various markets. The main focus is on feature-length movies with a budget of under $2 million.

The company also intends to develop projects in states that offer tax incentives for the film industry, reducing the need for added capital.

The initial amount of shares offered will be 1.485 million, with a projected price per share of $0.20.

An amended IPO registration was filed with the United States Securities and Exchange Commission on July 14th, 2011. This is a direct public offering, therefore there are no underwriters. A ticker symbol has yet to be announced.

Thunderclap Entertainment, Inc. S-1/A Form

Thunderclap Entertainment, Inc.

www.publicfinancial.com

TANGOE INC IPO

Tangoe Inc. is an Orange, Connecticut based company, that provides communication software including customer-management and phone billing software. Founded in 2000, Tangoe currently has more than 500 clients and has nine operation centers around the world, including the Netherlands and China.

It filed an S-1 IPO form with the United States Securities and Exchange Commission on July 14th, and shares will be available to the public shortly. The number of shares offered will be 8.8 million (7.5 million by the company and 1.27 million by shareholders), at a price of between $9 and $11.

After costs, the company expects to make about $66.6 million, which will be used as working capital and for corporate purposes, as well as to repay debt.

The chief underwriters of the IPO are Deutsche Bank and Stifel Nicolaus. Additional underwriters are Lazard Capital, Raymond James & Associates, Signal Hill Capital and Oppenheimer.

Tangoe Inc. will be listed on NASDAQ, under the ticker symbol ‘TNGO’.

TANGOE INC S-1/A Form

TANGOE INC

Reuters

Norwegian Cruise Line Holdings Ltd. IPO

Norwegian Cruise Lines filed their S-1 registration paperwork with the SEC to raise $250 million in an IPO on July 15. The company said they expect to use the proceeds of the IPO to pay down their debt, but no other financial details were reported.

It is the second filing for the company, following a previous S-1 filing in October 2010. The company withdrew that S-1, filed under NCL Corporation Ltd., and the new name of the parent company will be Norwegian Cruise Line Holdings Ltd.

Norwegian is the third largest cruise ship operator in North America, following Carnival Corp. and Royal Caribbean Cruise Ltd. Currently Norwegian is a privately held company owned by Genting HK, an Asian gaming company, and the investment group Apollo Management. Each owns 50% of Norwegian.

Norwegian was founded by businessmen Knut Kloster and Ted Arison and began operations in 1966. Norwegian is well known for their trademarked “”Freestyle Cruising”" concept, differing from other large cruise ship operators by featuring no set dining times, assigned tables or formal dress code. Norwegian operates in North America, the Mediterranean, the Baltic, Bermuda, Central America and the Caribbean, currently fielding a fleet of eleven ships.

Norwegian was bought by Star Cruises, a subsidiary of Genting HK, in 2000, but the company surprised industry observers when they sold 50% of their stake to the Apollo Group in 2007.

In October of 2010, a day before Norwegian’s initial IPO filing, the company announced orders for two new 143,500-ton ships from Germany’s Meyer Werft shipyard, set to enter service in 2013 and 2014. These two ships will be the largest ever built in Germany, each having a capacity of 4,000 passengers. The cost of the deal was reported as 1.2 billion euros and will expand Norwegian’s capacity by 30%.

Norwegian’s total revenues for the twelve months ending March 31, 2011 were $2.09 billion, with net revenues of $1.54 billion and net income of $28.10 million.

For the first quarter of 2011, revenues were up. Norwegian reported total revenues of $495.5 million, net revenues of $368.0 million, with a net loss of $10.6 million. In the first quarter of 2010 Norwegian reported total revenues of $416.5 million, net revenues of $306.9 million, with a net loss of $16.1 million.

Norwegian expects to trade on the Nasdaq under the stock symbol NCLH.

Find out more, visit:

Norwegian Cruise Line Holdings Ltd. S-1 Form

Norwegian Cruise Lines

Norwegian Cruise Line – Wikipedia

USA Today

Targeted Medical Pharma, Inc. IPO

Targeted Medical Pharma, Inc, is a pharmaceutical company specializing in the development of therapeutic systems for the nutritional management of chronic diseases. Founded in 1999 the company is based in Los Angeles, California and has 55 employees.

Targeted Medical Pharma, Inc develops treatments for illnesses such as pain syndromes, metabolic syndrome, sleep disorders, viral infection, hypertension, asthma, and obesity through medicinal food products.

Targeted Medical Pharma, Inc filed to go public in February of 2011. The price and number of shares has not yet been made available but the company hopes to raise about $118 million with the IPO. The lead underwriter is Sunrise Securities Corp. It will be trading on NASDAQ with the ticker symbol TMP.

Fiscal year-end sales for 2010 were $19,115,439 with a one year sales growth of 56%. The net income was $10.1 million.

Targeted Medical Pharma, Inc. S-1/A Form

Targeted Medical Pharma, Inc.

Bloomberg Businessweek